Alexander Chin, MD is a Clinical Assistant Professor at Stanford Medicine Children's Health in Stanford, CA. He specializes in Radiation Oncology and has extensive experience in treating non-small-cell lung cancer (NSCLC) with hypofractionated accelerated radiation therapy (HART) and concurrent chemotherapy. Dr. Chin's research focuses on patient selection, outcomes, and dosimetry to guide treatment decisions. He has published several studies on the effectiveness and safety of HART with concurrent chemotherapy for NSCLC patients, and his findings are being used to inform a prospective study on the safety and efficacy of this treatment approach. Additionally, Dr. Chin is involved in a phase I/II trial called Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer, which aims to evaluate a novel treatment approach based on the predicted toxicity to organs at risk.
Generated from the website